BCI researchers are lead members of an international team to be funded by an Accelerator Award, which will bring together scientists from the UK, Spain and Italy in a bid to improve early detection and intervention of blood cancers. The award of £4.8M over 5 years, funded through a partnership between Cancer Research UK (CRUK), AIRC and FC AECC, encourages cross-institutional collaboration to unite resources and expertise to accelerate progress in cancer research.

The Accelerator Award, led by Prof Jesus San Miguel, Director of Clinical and Translational Medicine at the University of Navarra, Spain, will support research into three types of blood cancer: follicular lymphoma, multiple myeloma and acute myeloid leukaemia, with each country acting as a specialist hub (across 13 centres) for one of these diseases. The three cancer types share similar features of progression, and the team hope to develop integrative models of how they evolve from a pre-malignant (or minimal residual disease) stage to malignant disease, and how best to target these cancers at their most vulnerable. (Read more)